Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 9778239)

Published in Cell on October 02, 1998

Authors

S S Sisodia1

Author Affiliations

1: Department of Pharmacological and Physiological Sciences, The University of Chicago, Illinois 60637, USA.

Articles citing this

Light quality-dependent nuclear import of the plant photoreceptors phytochrome A and B Plant Cell (1999) 3.64

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A (2000) 3.43

Dynamic association of proteasomal machinery with the centrosome. J Cell Biol (1999) 3.30

Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2000) 2.63

A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell (1999) 1.76

Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.52

The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51

Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol (2001) 1.42

Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am J Hum Genet (2000) 1.38

Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J (2002) 1.35

A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics (2010) 1.32

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philos Trans R Soc Lond B Biol Sci (1999) 1.21

CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse. Neurobiol Dis (2008) 1.19

CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases. Mol Cell Biol (2000) 1.16

The proteasome: a macromolecular assembly designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci (1999) 1.16

Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta (2009) 1.14

Formation and toxicity of soluble polyglutamine oligomers in living cells. PLoS One (2010) 1.12

Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11

The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci (2014) 1.10

Visceral neuropathy and intestinal pseudo-obstruction in a murine model of a nuclear inclusion disease. Gastroenterology (2007) 1.06

Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc Natl Acad Sci U S A (2003) 1.05

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum (2014) 1.03

Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? J Med Genet (1999) 1.03

Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc Natl Acad Sci U S A (2005) 1.00

Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99

Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease. Acta Neuropathol (2010) 0.98

Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model. J Biol Chem (2014) 0.83

Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol (2000) 0.82

Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia. Neurobiol Dis (2010) 0.79

The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease. Front Neurosci (2016) 0.77

Studying polyglutamine diseases in Drosophila. Exp Neurol (2015) 0.76

Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins. Sci Rep (2014) 0.75

Of mice and men: solving the molecular mysteries of Huntington's disease. J Anat (2000) 0.75

Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases. Front Cell Neurosci (2017) 0.75

CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins. MBio (2016) 0.75

Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains. J Neurol Neurosurg Psychiatry (2003) 0.75

RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev (2017) 0.75